Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium
Roberta B. Ness(The University of Texas Health Science Center at Houston), Brooke L. Fridley(Children's Mercy Hospital), Harvey A. Risch(University of New Haven), Chi‐Chen Hong(Roswell Park Comprehensive Cancer Center), Kunle Odunsi(University of Chicago), Ellen L. Goode(Mayo Clinic in Arizona), Jenny Chang‐Claude(Universität Hamburg), Robert A. Vierkant(Mayo Clinic), Linda E. Kelemen(Medical University of South Carolina), Anna DeFazio(The University of Sydney), Thilo Dörk(Hannover Re (Germany)), Stacey J. Winham(Mayo Clinic), Chiu-Chen Tseng(University of Southern California), Estrid Høgdall(University of Copenhagen), Michael J. LaMonte(Cooper Institute), J. Brian Szender(Roswell Park Comprehensive Cancer Center), Rikki Cannioto(Roswell Park Comprehensive Cancer Center), Susanne K. Kjær(Copenhagen University Hospital), Marc T. Goodman(Cedars-Sinai Medical Center), Andrew Berchuck(General Marble (Greece)), Catherine M. Olsen(QIMR Berghofer Medical Research Institute), Elizabeth A. Szamreta(Merck & Co., Inc., Rahway, NJ, USA (United States)), Brahm H. Segal(Roswell Park Comprehensive Cancer Center), Albina N. Minlikeeva(Roswell Park Comprehensive Cancer Center), Daniel W. Cramer(Brigham and Women's Hospital), Nicolas Wentzensen(National Cancer Institute), Grace Friel(Kaleida Health), Joellen M. Schildkraut(Duke University Hospital), Keitaro Matsuo(Aichi Cancer Center), Malcolm C. Pike(Kettering University), Janine M. Joseph(Roswell Park Comprehensive Cancer Center), Christina M. Nagle(The University of Queensland), Robert P. Edwards(Cancer Research UK Technology), Barbara Schmalfeldt(Universität Hamburg), Rüdiger Klapdor(Medizinische Hochschule Hannover), Anna H. Wu(University of Southern California), Lisa E. Paddock(Rutgers, The State University of New Jersey), Jennifer A. Doherty(Cancer Prevention Institute of California), Francesmary Modugno(University of Pittsburgh), Satoyo Hosono(Aichi Cancer Center), Brenda Diergaarde(University of Pittsburgh), Kristine G. Wicklund(German Cancer Research Center), Kevin H. Eng(Roswell Park Comprehensive Cancer Center), Celeste Leigh Pearce(University of Southern California), Pamela J. Thompson(University of Southern California), Mary Anne Rossing(Fred Hutch Cancer Center), Lara Sucheston‐Campbell(Roswell Park Comprehensive Cancer Center), Peter Hillemanns(Medizinische Hochschule Hannover), Joseph L. Kelley(Magee-Womens Hospital)
Cited by 48
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k